ArticleFrontiers in immunology2026
Multimodal integration of neuroimaging, transcriptomics and single-cell analysis reveals molecular correlates linking osteoporosis to brain abnormalities.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Osteoporosis (OP) and cognitive decline are highly prevalent comorbidities; however, the molecular mechanisms linking them remain unclear. We adopted a multimodal integrative strategy combining neuroimaging, transcriptomics, single-cell analysis, and in vivo validation to elucidate potential mechanisms. Methods: Fifty-six patients and fifty-three healthy controls underwent resting-state functional MRI (fMRI) to assess regional homogeneity (ReHo) and amplitude of low-frequency fluctuation (ALFF). Transcriptomic data from the Allen Human Brain Atlas (AHBA), single-nucleus RNA sequencing (snRNA-seq) of the human hippocampus, and validation using ovariectomized (OVX) mouse models were integrated. Results: fMRI revealed significant ALFF/ReHo alterations in the hippocampus, prefrontal cortex, and posterior cingulate cortex of OP patients, with the left hippocampal ALFF mediating the association between bone mineral density (BMD) and Montreal Cognitive Assessment (MoCA) scores. Spatial correlation analyses have linked these brain functional changes to neurotransmitter receptors (5-HT1a, D1, GABAa, etc.) and genes enriched in synaptic function, neurogenesis, and dopaminergic signaling. snRNA-seq identified the caudal hippocampus as a key region, with astrocytes enriched in OP-associated Gene Program 5 (involving NR4A3 and KCNIP1) and functional pathways such as glutamatergic synapses and calcium signaling. OVX mice showed bone loss, spatial learning/memory impairment, hippocampal astrocyte abnormalities, and upregulation of GFAP, RGS7, and RGS6 proteins. Conclusion: Our multimodal study establishes a molecular framework for the bone-brain axis, highlighting astrocytes and synaptic signaling as potential targets for the dual protection of bone and brain health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.